PFP. Margreet G. Filius

P. Margreet G. Filius

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


P. Margreet G. Filius has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • A. G. Vulto

    Hospital Pharmacy Erasmus MC University Medical Center Rotterdam, Dr Molewaterplein 40 3015 GD Rotterdam

    1 shared publication
  • A.G. Vulto

    1 shared publication
  • Alewijn Ott

    Department of Medical Microbiology and Infectious Diseases,1 Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands2

    1 shared publication
  • Arnold G. Vulto

    Department of Medical Microbiology and Infectious Diseases,1 Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands2

    1 shared publication
  • D. van Netten

    1 shared publication
  • H. A. Verbrugh

    Departments Medical Microbiology and Infectious Diseases

    1 shared publication

Latest Publications

  • Open Access

    Colonization and Resistance Dynamics of Gram-Negative Bacteria in Patients during and after Hospitalization

    by P. Margreet G. Filius, Inge C. Gyssens, Irma M. Kershof, Patty J. E. Roovers, Alewijn Ott, Arnold G. Vulto, Henri A. Verbrugh, Hubert P. Endtz

    The colonization and resistance dynamics of aerobic gram-negative bacteria in the intestinal and oropharyngeal microfloras of patients admitted to intensive care units (ICU) and general wards were investigated during and after hospitalization. A total of 3,316 specimens were obtained from patients upon admission, once weekly during hospitalization, at discharge from the ICU, at discharge from the hospital, and 1 and 3 months after discharge from the hospital. Five colonies per specimen were selected for identification and susceptibility testing. In both patient populations, the gram-negative colonization rates in oropharyngeal specimens increased during hospitalization and did not decrease in the 3 months after discharge. In rectal specimens, colonization rates decreased during hospitalization and increased after discharge. There was a change in species distribution among the dominant microfloras during hospitalization. Klebsiella spp., Enterobacter spp., Serratia marcescens , and Pseudomonas aeruginosa were isolated more often, whereas the frequency of Escherichia coli declined. The percentage of ICU patients colonized with ampicillin- and/or cephalothin-resistant fecal E. coli was significantly increased at discharge from the hospital and did not change in the 3 months after discharge. The emergence of multidrug resistance was observed for E. coli during patient stays in the ICU. Resistance frequencies in E. coli significantly increased with the length of stay in the ICU. For the general ward population, no significant changes in resistance frequencies were found during hospitalization. From a population perspective, the risk of dissemination of resistant gram-negative bacteria into the community through hospitalized patients appears to be low for general ward patients but is noticeably higher among ICU patients.


  • Open Access

    An additional measure for quantifying antibiotic use in hospitals

    by P. M. G. Filius, T. B. Y. Liem, P. D. van der Linden, R. Janknegt, S. Natsch, A. G. Vulto, H. A. Verbrugh

    Objectives: The number of defined daily doses (DDD) per 100 patient days is often used as an indicator for the selection pressure exerted by antibiotics in the hospital setting. However, this unit of measurement does not fully describe the selection pressure and is sensitive to changes in hospital resource indicators. Additional information is required to facilitate interpretation of this indicator. The number of DDD per 100 admissions could be a valuable additional tool. The aim of this study is to investigate the importance of units of measurement in quantifying antibiotic use data with regards to antibiotic resistance risks. Patients and methods: Trends in antibiotic use in acute care Dutch hospitals between 1997–2001 were studied. Antibiotic use was expressed in DDD per 100 patient days and in DDD per 100 admissions. Results: From 1997 to 2001, total systemic antibiotic use significantly increased from 47.2 to 54.7 DDD per 100 patient days, whereas expressed in DDD per 100 admissions it remained constant. Some individual antibiotics increases in DDD per 100 patient days were not accompanied by increases in DDD per 100 admissions and vice versa. The mean number of total DDD per hospital decreased (not significantly) between 1997 and 2001. The mean number of patient days, admissions and length of stay decreased significantly. Conclusions: Knowledge of variation in resource indicators and additional expression of the data in DDD per 100 admissions is imperative for a meaningful understanding of observed trends in antibiotic use expressed in DDD per 100 patient days. Further research is needed to determine the correlation between different measures of antibiotic use and the level of antibiotic resistance.